Amy Organics IPO The share allotment position is likely to be finalized tomorrow. The Rs 569 crore issue opened for subscription from September 1-3 with a price brand of Rs 603-610 per share. Ami Organics The public issue witnessed tremendous interest from investors in the IPO. The IPO issue was subscribed about 86.64 times by qualified institutional buyers during the trading day. However, retail institutional investors who saw 13.36x subscriptions by the end of the public issue. The allotment of the issue is likely to be finalized by tomorrow.
If you have invested in the IPO of Amy Organics, you can check the status of the share allotment on Wednesday. There are two ways to check share allotment application status – 1) through BSE, 2) through IPO registrar’s website.
How to Check Amy Organics IPO Allotment Status through BSE
1) You have to visit the official website of BSE through the URL (https://www.bseindia.com/investors/appli_check.aspx).
2) It will take you to a page named ‘Status of Issue Application’. There you have to select the ‘Equity’ option.
3) Select ‘Amy Organics Limited’ from the drop-down menu which is in addition to the name of the issue.
4) Input your Application Number and Permanent Account Number (PAN). You then click on ‘I am not a robot’ and click ‘Search’ to verify yourself. It will show you the status of the application.
How to Check Amy Organics IPO Allotment Status through Registrar’s Website (Link Intime India)
1) Visit the Link Intime India website using the URL: (https://www.linkintime.co.in/IPO/public-issues.html)
2) Select the option ‘Amy Organics Limited’ from the drop-down list under ‘Company’. Name will be filled only after finalization of allotment
3) You have to select any one of the three modes: Application Number, Client ID or PAN ID
4) In Application Type, choose between ASBA and Non-ASBA
5) Step 2. Enter the details of the mode you have selected in
6) Fill the captcha and enter the option ‘Submit’
Amy Organics IPO Gray Market Premium
The unlisted share of Amy Organics Ltd was trading at Rs 145, indicating that the issue was trading at a premium of Rs 738 to Rs 745 per equity share in the gray market. Amy Organics was born in 2004. The company is known for having a wide variety of advanced pharmaceutical intermediates and active pharmaceutical ingredients (APIs) in its diverse product portfolio. This time. The company has 450 developed pharma intermediates in various fields. Anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson’s, anti-depressant and anti-coagulant. Apart from this, Amy Organics is known for exporting medicines to various countries like USA, China, Israel, Japan, Latin America etc. In India, the company has three manufacturing units in Gujarat.
“Amy Organics Ltd. intends to pursue strategic acquisitions and partnerships to complement its organic growth and internal expertise. It also intends to develop its internal capabilities and production capabilities to achieve desired levels of organic growth. Pursuing strategic acquisitions, including the recently concluded acquisition of GOL’s business, Amy Organics will combine its capabilities and technical expertise or enter into partnerships to strengthen its product infrastructure and overall manufacturing capabilities in the specialty chemicals sector It is in the process of building its synergies and such inorganic expansion will help Amy Organics grow further,” said an analyst at HDFC Securities.
read all breaking news, breaking news And coronavirus news Here
.